Surface engineering of hollow gold nanoparticle with mesenchymal stem cell membrane and MUC-1 aptamer for targeted theranostic application against metastatic breast cancer.

[1]  S. M. Taghdisi,et al.  Synthesis of doxorubicin-loaded peptosomes hybridized with gold nanorod for targeted drug delivery and CT imaging of metastatic breast cancer , 2022, Journal of Nanobiotechnology.

[2]  S. M. Taghdisi,et al.  Synthesis of a targeted, dual pH and redox-responsive nanoscale coordination polymer theranostic against metastatic breast cancer in vitro and in vivo , 2022, Expert opinion on drug delivery.

[3]  S. M. Taghdisi,et al.  Targeted biomimetic hollow mesoporous organosilica nanoparticles for delivery of doxorubicin to colon adenocarcinoma: In vitro and in vivo evaluation , 2022, Microporous and Mesoporous Materials.

[4]  S. M. Taghdisi,et al.  Development of PNC-27 targeted codelivery system for survivin-shRNA and SN38 against colon adenocarcinoma in vitro and in vivo , 2022, Journal of Drug Delivery Science and Technology.

[5]  S. Hudoklin,et al.  Encapsulation of doxorubicin prodrug in heat-triggered liposomes overcomes off-target activation for advanced prostate cancer therapy. , 2021, Acta biomaterialia.

[6]  S. M. Taghdisi,et al.  Aptamer targeted red blood cell membrane-coated porphyrinic copper-based MOF for guided photochemotherapy against metastatic breast cancer , 2021 .

[7]  E. Tasciotti,et al.  Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles , 2021, Nature Communications.

[8]  Liming Shen,et al.  Synthesis of gold nanorods and their performance in the field of cancer cell imaging and photothermal therapy , 2021, Cancer Nanotechnology.

[9]  Jae-Hyuk Kim,et al.  Recent Advances in Hollow Gold Nanostructures for Biomedical Applications , 2021, Frontiers in Chemistry.

[10]  S. M. Taghdisi,et al.  Self-targeted polymersomal co-formulation of doxorubicin, camptothecin and FOXM1 aptamer for efficient treatment of non-small cell lung cancer. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Y. Tabata,et al.  Active stealth and self-positioning biomimetic vesicles achieved effective antitumor therapy. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[12]  S. M. Taghdisi,et al.  Fabrication of versatile targeted lipopolymersomes for improved camptothecin efficacy against colon adenocarcinoma in vitro and in vivo , 2021, Expert opinion on drug delivery.

[13]  L. Fabris Gold Nanostars in Biology and Medicine: Understanding Physicochemical Properties to Broaden Applicability , 2020 .

[14]  S. M. Taghdisi,et al.  Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer. , 2020, Life sciences.

[15]  Sanjay Gupta,et al.  Doxorubicin-loaded hollow gold nanospheres for dual photothermal ablation and chemoembolization therapy , 2020, Cancer Nanotechnology.

[16]  S. M. Taghdisi,et al.  Synthesis of chimeric polymersomes based on PLA-b-PHPMA and PCL-b-PHPMA for nucleoline guided delivery of SN38. , 2020, Nanomedicine : nanotechnology, biology, and medicine.

[17]  J. C. Possato,et al.  Comparative cytotoxic effect of citrate-capped gold nanoparticles with different sizes on noncancerous and cancerous cell lines , 2020, Journal of Nanoparticle Research.

[18]  S. Mitragotri,et al.  Targeting Strategies for Tissue-Specific Drug Delivery , 2020, Cell.

[19]  S. M. Taghdisi,et al.  Hybrid nanoreservoirs based on dextran‐capped dendritic mesoporous silica nanoparticles for CD133‐targeted drug delivery , 2020, Journal of cellular physiology.

[20]  K. Lim,et al.  Osteogenic potential of human mesenchymal stem cells on eggshells-derived hydroxyapatite nanoparticles for tissue engineering. , 2019, Journal of biomedical materials research. Part B, Applied biomaterials.

[21]  Z. Yin,et al.  Hollow gold nanoshells-incorporated injectable genetically engineered hydrogel for sustained chemo-photothermal therapy of tumor , 2019, Journal of nanobiotechnology.

[22]  Yi-Nan Wang,et al.  Preparation of novel cisplatin‐conjugated hollow gold nanospheres for targeting cervical cancer , 2019, Journal of cellular physiology.

[23]  Ming Chen,et al.  Cancer cell membrane cloaking nanoparticles for targeted co-delivery of doxorubicin and PD-L1 siRNA , 2019, Artificial cells, nanomedicine, and biotechnology.

[24]  T. Webster,et al.  PEGylated hollow gold nanoparticles for combined X-ray radiation and photothermal therapy in vitro and enhanced CT imaging in vivo. , 2019, Nanomedicine : nanotechnology, biology, and medicine.

[25]  S. M. Taghdisi,et al.  Peptide‐based targeted therapeutics: Focus on cancer treatment , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Mine Silindir-Gunay,et al.  Theranostic polymeric nanoparticles for NIR imaging and photodynamic therapy , 2018, International journal of pharmaceutics.

[27]  S. M. Taghdisi,et al.  Curcumin‐entrapped MUC‐1 aptamer targeted dendrimer‐gold hybrid nanostructure as a theranostic system for colon adenocarcinoma , 2018, International journal of pharmaceutics.

[28]  Saji Uthaman,et al.  Cell Membrane-Camouflaged Nanoparticles: A Promising Biomimetic Strategy for Cancer Theragnostics , 2018, Polymers.

[29]  C. Xiong,et al.  Cisplatin-loaded hollow gold nanoparticles for laser-triggered release , 2018, Cancer Nanotechnology.

[30]  Bin Wang,et al.  Surface Functionalization of Polymeric Nanoparticles with Umbilical Cord-Derived Mesenchymal Stem Cell Membrane for Tumor-Targeted Therapy. , 2018, ACS applied materials & interfaces.

[31]  H. Wakelee,et al.  Incidence of lung cancer histologic cell-types according to neighborhood factors: A population based study in California , 2018, PloS one.

[32]  T. Webster,et al.  The comparative effect of wrapping solid gold nanoparticles and hollow gold nanoparticles with doxorubicin-loaded thermosensitive liposomes for cancer thermo-chemotherapy. , 2018, Nanoscale.

[33]  M. Stenzel,et al.  Entry of nanoparticles into cells: the importance of nanoparticle properties , 2018 .

[34]  Vikesh Chhabria,et al.  Cell membrane coated nanoparticles: next-generation therapeutics. , 2017, Nanomedicine.

[35]  O. K. Abubakre,et al.  Application of gold nanoparticles for improved drug efficiency , 2017 .

[36]  Wahid Khan,et al.  Liposomal Formulations in Clinical Use: An Updated Review , 2017, Pharmaceutics.

[37]  Xiangdong Wang,et al.  Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy. , 2017, Seminars in cancer biology.

[38]  M. Ramezani,et al.  Polyethylenimine-functionalized carbon nanotubes tagged with AS1411 aptamer for combination gene and drug delivery into human gastric cancer cells. , 2017, International journal of pharmaceutics.

[39]  C. Murphy,et al.  One low-dose exposure of gold nanoparticles induces long-term changes in human cells , 2016, Proceedings of the National Academy of Sciences.

[40]  P. Grigsby,et al.  Drug Delivery Approaches for the Treatment of Cervical Cancer , 2016, Pharmaceutics.

[41]  N. Mohallem,et al.  A comparison of TEM and DLS methods to characterize size distribution of ceramic nanoparticles , 2016 .

[42]  K. Kataoka,et al.  Hydroxychloroquine-conjugated gold nanoparticles for improved siRNA activity. , 2016, Biomaterials.

[43]  Yaojiong Wu,et al.  Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential , 2016, Cellular and Molecular Life Sciences.

[44]  I. Yarovsky,et al.  Gold Nanoparticles: Understanding and Designing the Gold-Bio Interface: Insights from Simulations (Small 18/2016). , 2016, Small.

[45]  S. M. Taghdisi,et al.  A novel fluorescent aptasensor based on gold and silica nanoparticles for the ultrasensitive detection of ochratoxin A. , 2016, Nanoscale.

[46]  Liangfang Zhang,et al.  Cell membrane-camouflaged nanoparticles for drug delivery. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[47]  Jianxun Ding,et al.  Epirubicin-Complexed Polypeptide Micelle Effectively and Safely Treats Hepatocellular Carcinoma , 2015 .

[48]  M. Bentires-Alj,et al.  Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy. , 2015, Molecular cell.

[49]  Yuan-Cheng Cao,et al.  Preparation, Modification, and Application of Hollow Gold Nanospheres , 2015 .

[50]  M. Ramezani,et al.  The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[51]  M. Ramezani,et al.  In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[52]  E. Choi,et al.  Multifunctional hollow gold nanoparticles designed for triple combination therapy and CT imaging. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[53]  Ashutosh Tiwari,et al.  Functionalized Gold Nanoparticles: Synthesis, Properties and Applications--A Review. , 2015, Journal of nanoscience and nanotechnology.

[54]  Ronnie H. Fang,et al.  Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery , 2014, Nano letters.

[55]  G. Milano,et al.  Challenges, expectations and limits for nanoparticles-based therapeutics in cancer: a focus on nano-albumin-bound drugs. , 2013, Critical reviews in oncology/hematology.

[56]  S. Honary,et al.  Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 2) , 2013 .

[57]  D. Kufe MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches , 2013, Oncogene.

[58]  Y. Barenholz Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[59]  Mingwu Shen,et al.  PEGylated dendrimer-entrapped gold nanoparticles for in vivo blood pool and tumor imaging by computed tomography. , 2012, Biomaterials.

[60]  Chun Li,et al.  Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release. , 2010, ACS nano.

[61]  Younan Xia,et al.  Gold nanocages: synthesis, properties, and applications. , 2008, Accounts of chemical research.

[62]  Robert Gurny,et al.  Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[63]  Sangjin Park,et al.  Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. , 2007, Journal of the American Chemical Society.

[64]  Tammy Y. Olson,et al.  Synthesis, characterization, and tunable optical properties of hollow gold nanospheres. , 2006, The journal of physical chemistry. B.

[65]  G. Apodaca,et al.  Clathrin-mediated endocytosis of MUC1 is modulated by its glycosylation state. , 2000, Molecular biology of the cell.

[66]  D. Kufe,et al.  MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer. , 2018, Cancer research.

[67]  Michael S. Ewer,et al.  Cardiotoxicity of anticancer treatments , 2015, Nature Reviews Cardiology.

[68]  Michael A. Hollingsworth,et al.  Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.